SHAPOVAL, O S and VORONTSOVA, L L. Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors. Journal of Education, Health and Sport. Online. 16 January 2015. Vol. 5, no. 1, pp. 75-86. [Accessed 9 May 2024].